- Home
- CAG vs PCVX Comparison
CAG vs PCVX Comparison
Compare CAG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAG | PCVX |
|---|---|---|
| Founded | 1919 | 2013 |
| Country | United States | United States |
| Employees | 26100 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 6.1B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CAG | PCVX |
|---|---|---|
| Price | $15.75 | $54.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | $18.86 | ★ $98.33 |
| AVG Volume (30 Days) | ★ 13.6M | 1.1M |
| Earning Date | 04-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 8.90% | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,500,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.04 | $28.09 |
| 52 Week High | $27.68 | $65.00 |
Technical Indicators
Market Signals| Indicator | CAG | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 46.90 |
| Support Level | N/A | $42.30 |
| Resistance Level | $19.54 | $56.04 |
| Average True Range (ATR) | 0.52 | 2.27 |
| MACD | -0.05 | -0.35 |
| Stochastic Oscillator | 32.39 | 39.05 |
Price Performance
Historical ComparisonAbout CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.